Inhibition of PCR in Genital and Urine Specimens Submitted for Chlamydia trachomatis Testing

AUTOR(ES)

Toye, B.

FONTE

American Society for Microbiology

RESUMO

We determined the frequency of PCR inhibition in genital and urine specimens submitted for Chlamydia trachomatis testing using the internal control DNA provided with the COBAS AMPLICOR C. trachomatis test and assessed methods to remove it. Inhibition occurred in 65 of 906 (7%) cervical swabs, 23 of 51 (45%) urethral swabs, and 2 of 175 (1.1%) urine samples. Overall, inhibition was eliminated in processed specimens after storage at 4°C in 77 of 90 specimens (86%), freezing at −70°C in 59 of 82 specimens (72%), storage at 4°C followed by either 1:100 dilution in 37 of 43 specimens (86%) or 1:10 dilution in 42 of 47 specimens (89%), and phenol-chloroform extraction in 79 of 80 specimens (99%). No positive specimens were missed due to inhibition. We conclude that PCR inhibition is rare with urine specimens and infrequent with endocervical swabs but occurs frequently with urethral swabs. The frequency of PCR inhibition may be significantly reduced by methods which can be easily incorporated into the processing of specimens.

Documentos Relacionados

• Diagnosis of genital Chlamydia trachomatis infections in asymptomatic males by testing urine by PCR.
• Efficacy of duplicate genital specimens and repeated testing for confirming positive results for chlamydiazyme detection of Chlamydia trachomatis antigen.
• Pooling of Clinical Specimens Prior to Testing for Chlamydia trachomatis by PCR Is Accurate and Cost Saving
• Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens.
• Detection of Chlamydia trachomatis in male and female urine specimens by using the amplified Chlamydia trachomatis test.